Gene therapy for Duchenne muscular dystrophy provides hope, raises concerns - Arizona Daily Star

Excerpt

Now, those ages 4 and older, who have the genetic mutation and are able to walk can receive the therapy. The FDA also conditionally approved Elevidys ...